Decline in the nationwide trends in in-hospital mortality of patients undergoing multivessel percutaneous coronary intervention

Journal of Invasive Cardiology

Volumn 21, Issue 8, 2009, Pages 388-390

  Movahed, Mohammad Reza ^a,b   Ramaraj, Radhakrishnan ^b   Jamal, M Mazen ^b   Hashemzadeh, Mehrtash ^c  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ETHNICITY; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; MALE; MORTALITY; PATIENT CARE; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; UNITED STATES;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 69249158213     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: One- to eight-year outcomes. J Am Coll Cardiol 2003;41:1293-1304.
2. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005; 352:2174-2183. (Pubitemid 40727084)
3. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update: Endorsed by the National Heart, Lung and Blood Institute. Circulation 2006;113:2363-2372.
4. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350:221-231. (Pubitemid 38067635)
5. Ong AT, van der Giessen WJ. Drug-eluting stents for interventional revascularization of coronary multivessel disease. J Interv Cardiol 2005;18:447-453. (Pubitemid 41726994)
6. Versaci F, Gaspardone A, Tomai F, et al. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997;336:817-822. (Pubitemid 27132978)
7. Rankin JM, Spinelli JJ, Carere RG, et al. Improved clinical outcome after widespread use of coronary-artery stenting in Canada. N Engl J Med 1999;341:1957-1965.
8. Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-589. (Pubitemid 28435240)
9. Kastrati A, Elezi S, Dirschinger J, et al. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 1999; 83:1617-1622. (Pubitemid 29288003)
10. Kobayashi Y, De Gregorio J, Kobayashi N, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999; 34:651-659. (Pubitemid 29436167)
11. Holmes DR Jr, Savage M, LaBlanche JM, et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2002;106:1243-1250. (Pubitemid 34988643)
12. Wilensky RL, Tanguay JF, Ito S, et al. Heparin infusion prior to stenting (HIPS) trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am Heart J 2000;139:1061-1070. (Pubitemid 30390337)
13. Kutryk MJ, Foley DP, van den Brand M, et al. Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: Results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial. J Am Coll Cardiol 2002;39:281-287.
14. Katritsis DG, Karvouni E, Ioannidis JP. Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol 2005;95:640-643. (Pubitemid 40255258)
15. Reul RM. Will drug-eluting stents replace coronary artery bypass surgery? Tex Heart Inst J 2005;32:323-330. (Pubitemid 41306788)
16. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323. (Pubitemid 37186209)
17. Arampatzis CA, Hoye A, Lemos PA, et al. Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: One-year clinical outcomes of 99 consecutive patients - the Rotterdam experience. Catheter Cardiovasc Interv 2004;63:57-60. (Pubitemid 39167082)
18. Orlic D, Bonizzoni E, Stankovic G, et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: Immediate and mid-term results. J Am Coll Cardiol 2004;43:1154-1160. (Pubitemid 38452589)
19. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimuseluting stents compared with conventional bare stent implantation in the "real world": The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004;109:190-195.
20. Ong AT, Serruys PW, Aoki J, et al. The unrestricted use of paclitaxel- versus sirolimuseluting stents for coronary artery disease in an unselected population: One-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol 2005;45:1135-1141. (Pubitemid 40432449)
21. Shishehbor MH, Topol EJ, Mukherjee D, et al. Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol 2006;97:1585-1590. (Pubitemid 43737028)
22. Mack MJ, Brown PP, Kugelmass AD, et al. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 Surgical and percutaneous procedures. Ann Thorac Surg 2004;77:761-766; Discussion 766-768.
23. Patti G, Nusca A, Chello M, et al. Usefulness of statin pretreatment to prevent contrastinduced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. Am J Cardiol 2008;101:279-285. (Pubitemid 351162953)
24. Ebrahimi R, Saleh J, Toggart E, et al. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis. J Invasive Cardiol 2008;20:292-295. (Pubitemid 351940887)
25. Mood GR, Bavry AA, Roukoz H, et al. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention. Am J Cardiol 2007;100:919-923. (Pubitemid 47368096)